Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Colorcon
Mallinckrodt
Merck
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for AMANTADINE HYDROCHLORIDE at ClinicalTrialExchange

DrugPatentWatch Database Preview

AMANTADINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Amantadine Hydrochloride, and when can generic versions of Amantadine Hydrochloride launch?

Amantadine Hydrochloride is a drug marketed by Actavis Elizabeth, Alembic Pharms Ltd, Bionpharma Inc, Heritage Pharma, Invagen Pharms, Lannett Co Inc, Novelgenix Theraps, Rubicon, Sandoz, Strides Pharma, Upsher Smith Labs, Watson Labs, Watson Labs Inc, Zydus Pharms, Akorn, Anda Repository, Cmp Pharma Inc, G And W Labs Inc, Pharm Assoc, Teva Pharms, Vintage, Wockhardt Bio Ag, and Jubilant Generics. and is included in thirty-one NDAs.

The generic ingredient in AMANTADINE HYDROCHLORIDE is amantadine hydrochloride. There are seven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amantadine Hydrochloride

A generic version of AMANTADINE HYDROCHLORIDE was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.

  Try it Free

Drug patent expirations by year for AMANTADINE HYDROCHLORIDE
Recent Clinical Trials for AMANTADINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
All India Institute of Medical Sciences, BhubaneswarPhase 4
Indian Council of Medical ResearchPhase 4
Copenhagen University Hospital, HvidovrePhase 3

See all AMANTADINE HYDROCHLORIDE clinical trials

Pharmacology for AMANTADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for AMANTADINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for AMANTADINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for AMANTADINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
GOCOVRI CAPSULE, EXTENDED RELEASE;ORAL amantadine hydrochloride 208944 2020-04-30
GOCOVRI CAPSULE, EXTENDED RELEASE;ORAL amantadine hydrochloride 208944 2018-01-16

US Patents and Regulatory Information for AMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novelgenix Theraps AMANTADINE HYDROCHLORIDE amantadine hydrochloride TABLET;ORAL 210215-001 Mar 10, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Strides Pharma AMANTADINE HYDROCHLORIDE amantadine hydrochloride TABLET;ORAL 209035-001 Jun 9, 2017 BX RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Actavis Elizabeth AMANTADINE HYDROCHLORIDE amantadine hydrochloride CAPSULE;ORAL 077659-001 Feb 23, 2006 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
G And W Labs Inc AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 072655-001 Oct 30, 1990 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Wockhardt Bio Ag AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 075060-001 Dec 24, 1998 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Dow
Mallinckrodt
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.